Wysong, A.; Somani, A. .; Ibrahim, . S.; Cañueto, J. .; Fitzgerald, A. .; Siegel, J. .; Prasai, A.; Goldberg, M.; Farberg, A.; Kasprzak, J. .; Brodland, D. .; Koyfman, S.; Arron, S. . Incorporating the 40-Gene Expression Profile (40-GEP) Test Within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed With Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors. J of Skin 2024, 8, s334.